DK2905288T3 - Syntetiske kunstige peptider med antimikrobiel virkning - Google Patents

Syntetiske kunstige peptider med antimikrobiel virkning Download PDF

Info

Publication number
DK2905288T3
DK2905288T3 DK15153281.9T DK15153281T DK2905288T3 DK 2905288 T3 DK2905288 T3 DK 2905288T3 DK 15153281 T DK15153281 T DK 15153281T DK 2905288 T3 DK2905288 T3 DK 2905288T3
Authority
DK
Denmark
Prior art keywords
peptide
peptides
amino acids
antimicrobial
seq
Prior art date
Application number
DK15153281.9T
Other languages
English (en)
Inventor
Karsten Rapsch
Nickisch-Rosenegk Markus V
Original Assignee
Fraunhofer Ges Forschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung filed Critical Fraunhofer Ges Forschung
Application granted granted Critical
Publication of DK2905288T3 publication Critical patent/DK2905288T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Claims (14)

1. Et peptid med et aminoterminalt område A, et carboxyterminalt område C og et derimellem liggende område B med den almene formel AxByCz f med x, z > 1, idet x > 3 og/eller z > 3, y>3ogx + y+ z< 50, idet A og C hver især uafhængigt af hinanden har i det mindste 65%, 75% eller 80% basiske aminosyrer, idet B har i det mindste 80% hydrofobe og/eller upolære aminosyrer udvalgt af gruppen bestående af Val, Ile, Phe og vilkårlige kombinationer af Val, Leu, Ile og Phe og omfatter en direkte rækkefølge efter hinanden af i det mindste tre, fire eller fem hydrofobe aminosyrer.
2. Peptid ifølge krav 1 med y > 4 eller y > 5.
3. Peptid ifølge et af kravene 1 eller 2, idet den aminoterminale aminosyre i A og/eller den carboxyterminale aminosyre i C er en basisk aminosyre.
4. Peptid ifølge et af kravene 1 til 3, idet de basiske aminosyrer uafhængigt af hinanden er udvalgt af gruppen bestående af Lys, Arg og His eller af Lys og Arg.
5. Peptid ifølge et af kravene 1 til 4, idet A og/eller C udelukkende omfatter basiske aminosyrer, og/eller idet B udelukkende omfatter hydrofobe og/eller upolære aminosyrer.
6. Peptid ifølge et af kravene 1 til 5 med y < 20, y < 15 eller y < 10 og/eller med x + y + z < 30 eller x + y + z < 20.
7. Peptid ifølge et af kravene 1 til 6, idet peptidet i et vandigt miljø i det mindste delvist er udformet som beta-streng, fortrinsvis i det mindste 50%, 65%, 75% eller 80% af aminosyrerne i peptidet er omfattet i en enkelt beta-streng.
8. Peptid ifølge et af kravene 1 til 7, idet peptidet i et vandigt miljø ikke har nogen alpha-helix.
9. Peptid ifølge et af kravene 1 til 8, idet peptidet på C-terminalen er udformet som carboxylsyreamid.
10. Peptid ifølge et af kravene 1 til 9 med 3 d x, z < 7 og 5 < y < 10, idet A og C uafhængigt af hinanden er udvalgt af gruppen bestående af Lys, Arg og kombinationer heraf, og idet B er udvalgt af gruppen bestående af Val, Ile, Phe og vilkårlige kombinationer af Val, Leu, Ile og Phe.
11. Peptid ifølge et af kravene 1 til 10, idet peptidet har i det mindste 90% eller i det mindste 95% sekvensidentitet med en sekvens udvalgt af gruppen bestående af SEQ ID NO: 1-13, 15, 16, 19-25 og 27-49.
12. Peptid ifølge et af kravene 1 til 11 til anvendelse som medikament.
13. Et konjugat omfattende peptidet ifølge et af kravene 1 til 11 og i det mindste en yderligere bestanddel, hvortil peptidet foreligger bundet kovalent og/eller adsorptivt
14. En antimikrobiel sammensætning omfattende peptidet ifølge et af kravene 1 til 11.
DK15153281.9T 2014-02-11 2015-01-30 Syntetiske kunstige peptider med antimikrobiel virkning DK2905288T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102014101663.7A DE102014101663A1 (de) 2014-02-11 2014-02-11 Synthetische artifizielle Peptide mit antimikrobieller Wirkung

Publications (1)

Publication Number Publication Date
DK2905288T3 true DK2905288T3 (da) 2019-04-15

Family

ID=52434638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15153281.9T DK2905288T3 (da) 2014-02-11 2015-01-30 Syntetiske kunstige peptider med antimikrobiel virkning

Country Status (4)

Country Link
US (1) US10556926B2 (da)
EP (1) EP2905288B1 (da)
DE (1) DE102014101663A1 (da)
DK (1) DK2905288T3 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2463181B (en) 2007-05-14 2013-03-27 Univ New York State Res Found Induction of a physiological dispersion response in bacterial cells in a biofilm
CA2867903C (en) 2012-03-23 2023-02-14 Amicrobe, Inc. Compositions and uses of antimicrobial materials with tissue-compatible properties
AU2018249552A1 (en) 2017-04-06 2019-10-31 Amicrobe, Inc. Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
WO2024106940A1 (ko) * 2022-11-16 2024-05-23 대한뉴팜㈜ 신규 항바이러스 펩타이드

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8900130L (sv) 1989-01-16 1990-07-17 Klaus Mosbach Konceptet att med hjaelp av molekylavtrycksmetoden framstaella konstgjorda antikroppar genom imprinting av t ex antigener samt att framstaella konstgjorda entzymer genom imprintning med transition state analoger
US5958786A (en) 1997-08-05 1999-09-28 Bayer Corporation Fluorescent polymeric sensor for the detection of creatinine
ATE428688T1 (de) 2000-01-28 2009-05-15 Mip Technologies Ab Funktionelle monomere zur molekularen erkennung und katalyse
JP3701608B2 (ja) 2000-05-23 2005-10-05 ラジオメーター・メディカル・アー・ペー・エス センサーメンブラン、その調製方法、センサー及びそのようなセンサーのための層状メンブラン構造体
AU2003223923A1 (en) * 2002-05-01 2003-11-17 Pantheco A/S Peptide nucleic acid conjugates with transporter peptides
US20080131451A1 (en) * 2004-03-05 2008-06-05 Giancarlo Tanzi Epitope escape mutations
JP2006067968A (ja) * 2004-09-06 2006-03-16 Osaka Bioscience Institute ヒト癌細胞の浸潤と転移を阻害する物質およびそのスクリーニング方法
ATE450620T1 (de) 2004-10-05 2009-12-15 Siemens Healthcare Diagnostics Stabiler kreatinin-biosensor mit drei enzymen
DE102004049805A1 (de) 2004-10-12 2006-04-13 Universität Dortmund Verfahren zur Herstellung von molekulargeprägten Polymeren zur Erkennung von Zielmolekülen
EP1824976A4 (en) * 2004-11-12 2008-07-09 Univ British Columbia ANTIMICROBIAL PEPTIDES
WO2006127048A2 (en) * 2004-12-17 2006-11-30 Kansas State University Research Foundation NOVEL pH DEPENDENT ADHESIVE PEPTIDES
EP1757942A1 (en) * 2005-08-26 2007-02-28 Max-Delbrück-Centrum Array for identification of protein-protein interactions and method for manufacturing the same
WO2008022444A1 (en) * 2006-08-21 2008-02-28 The University Of British Columbia Small cationic antimicrobial peptides
US9329186B2 (en) 2007-11-12 2016-05-03 Mip Technologies Ab Imprinted polymers with affinity for phosphorylated peptides and proteins
EP2168590A1 (en) * 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
CN102206250B (zh) * 2010-03-29 2017-03-15 翔升科技股份有限公司 低血球溶解性的抗微生物肽、药物组合物及其用途
GB201016733D0 (en) * 2010-10-05 2010-11-17 Novabiotics Ltd Compounds and their use
US10174081B2 (en) * 2011-04-21 2019-01-08 George Mason Research Foundation, Inc. Antimicrobial peptides and uses therefore

Also Published As

Publication number Publication date
DE102014101663A1 (de) 2015-08-13
EP2905288A1 (de) 2015-08-12
EP2905288B1 (de) 2018-12-26
US10556926B2 (en) 2020-02-11
US20150225458A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
Boparai et al. Mini review on antimicrobial peptides, sources, mechanism and recent applications
Sarkar et al. Antimicrobial peptides and proteins: From nature’s reservoir to the laboratory and beyond
Datta et al. Antimicrobial peptides as potential therapeutic agents: a review
Rajasekaran et al. LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity
Gaglione et al. Novel human bioactive peptides identified in Apolipoprotein B: Evaluation of their therapeutic potential
Sahoo et al. Antimicrobial peptides derived from insects offer a novel therapeutic option to combat biofilm: A review
Mojsoska et al. Peptides and peptidomimetics for antimicrobial drug design
Lai et al. Highly stabilized α-helical coiled coils kill gram-negative bacteria by multicomplementary mechanisms under acidic condition
Ma et al. Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of α-helix-based peptide amphiphiles
CN101801995B (zh) 抗菌肽
Tonk et al. The medical potential of antimicrobial peptides from insects
DK2905288T3 (da) Syntetiske kunstige peptider med antimikrobiel virkning
Mangoni et al. Structure− activity relationship, conformational and biological studies of temporin L analogues
JP6683601B2 (ja) 抗菌性ペプチド
Santos-Filho et al. Synthesis and characterization of an antibacterial and non-toxic dimeric peptide derived from the C-terminal region of Bothropstoxin-I
Ferreira Cespedes et al. Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus
Kumar et al. Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization
Ben Hur et al. Antimicrobial peptides against multidrug-resistant Pseudomonas aeruginosa biofilm from cystic fibrosis patients
Lu et al. Isolation, characterization and anti-cancer activity of SK84, a novel glycine-rich antimicrobial peptide from Drosophila virilis
KR20190067236A (ko) 엔테로코커스 박테리아에 대한 신규한 항미생물제
Rajasekaran et al. The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities
Li et al. Biomolecular engineering of a human beta defensin model for increased salt resistance
Dong et al. Novel design of short antimicrobial peptides derived from the bactericidal domain of avian β-defensin-4
Kim et al. Effects of the synthetic coprisin analog peptide, CopA3 in pathogenic microorganisms and mammalian cancer cells
Parai et al. Antimicrobial peptides: an approach to combat resilient infections